Expanded Potential Stem Cell lines of pig and human cells established
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells. These stem cells have the features of the very first cells in the developing embryo, and can develop into any type of cell. The research from LKS Faculty of Medicine of The University of Hong Kong (HKUMed), the Wellcome Sanger Institute, and the Friedrich-Loeffler-Institut in Germany offers incredible potential for studying human development and regenerative medicine.
The study published in Nature Cell Biology today (3rd June) is the first time scientists have been able to derive stem cells from early pig embryos. Domestic pigs have great potential for biomedical research because of their genetic and anatomical similarities to humans, including comparable organ sizes. Being able to genetically-modify pig stem cells will also be beneficial for animal health and food production.
Stem cells have the ability to develop into other cell types, and existing stem cell lines are already extremely useful for research into development, disease and treatments. However, currently available types of stem cell lines have limitations, and until now it has also not been possible to create embryonic stem cells from pigs and many other farm animals.
“Scientists have been attempting to derive porcine embryonic stem cells for decades without much success. With our Expanded Potential Stem Cell technology, we have now successfully derived and characterised stem cells from porcine preimplantation embryos. We have also established similar human stem cells. Our study represents a significant advance in stem cell research.”
Professor Pentao Liu, the leader of the study from the School of Biomedical Sciences and Stem Cell and Regenerative Medicine Consortium, HKUMed, and previously of the Wellcome Sanger Institute
Since human EPSCs can produce large numbers of placenta cells – called trophoblasts – they offer new opportunities to investigate pregnancy complications such as pre-eclampsia and miscarriages.
EPSCs come from culturing cells from the earliest stage of development, when the fertilised egg has only divided into 4 or 8 cells and the cells retain some totipotency – the ability to produce all cell types.
“These EPSC stem cells possess developmental potency that is not generally seen in conventional embryonic or induced pluripotent stem cells. They have the potential to produce all embryonic and extra-embryonic cell lines – including those in the placenta and yolk sac, turning back the development clock to the very earliest cell type. These cells will enable researchers to study early embryonic development, miscarriage and developmental disorders.”
Dr Xuefui Gao, a first author on the paper from HKUMed, and previously from the Wellcome Sanger Institute
The first EPSCs were created in 2017, when the group targeted key molecular pathways during very early development in mice. At these very earliest embryonic developmental stages, mammalian species are very similar and the cells are like a blank sheet of paper. This study has shown that it is possible to use the same approach to create human EPSCs and also to establish EPSCs from pigs – mammals that had previously been elusive to stem cell researchers.
“Our porcine EPSCs isolated from pig embryos are the first well-characterized pig cell lines worldwide. EPSC’s great potential to develop into any type of cell provides important implications for developmental biology, regenerative medicine, organ transplantation, disease modelling, and screening for drugs.”
Dr Monika Nowak-Imialek, an author on the paper from the Friedrich-Loeffler-Institut (FLI) in Germany
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- Cutting edge NZ research aims to improve life-saving stem cell treatmenton November 16, 2019 at 3:55 pm
Stem cell research to treat cancer and a range of life-threatening diseases could be made cheaper and more effective thanks to cutting edge research by a Christchurch engineer. Dr Azadeh Hashemi will ...
- Guiding T lymphopoiesis from pluripotent stem cells by defined transcription factorson November 16, 2019 at 5:25 am
Achievement of immunocompetent and therapeutic T lymphopoiesis from pluripotent stem cells (PSCs) is a central aim in T cell regenerative medicine. To date, preferentially reconstituting T ...
- 'I Got Nothing for My Money': Patients, Doctors Question 'Stem Cell' Therapyon November 16, 2019 at 2:32 am
Marilyn Kirchoff is in pain. "I've got tears in my rotator cuffs," she says. "Complete tears. I had this really bad pain in my hip, going down my leg. It pretty much limited me." The retired computer ...
- New Tech Extracts Stem Cells From Wisdom Teethon November 15, 2019 at 5:31 pm
But, along with some anxiety, having his wisdom teeth extracted by oral surgeon Dr. Tyler Boynton is also giving him hope. That’s because it has been discovered that wisdom teeth are a great source of ...
- Ballot initiative takes shape to give California stem cell agency a second lifeon November 15, 2019 at 2:50 pm
As California’s stem cell research agency runs through the last of its $3 billion in state funding, a delicate negotiation is underway between its leadership and the man developing the 2020 ballot ...
- 'Stem Cell' Clinics Offer Pain Relief, But Does it Work?on November 14, 2019 at 11:58 pm
"Complete tears. I had this really bad pain in my hip, going down my leg. It pretty much limited me." US Lawsuit Targets California, Florida Stem Cell Clinics The retired computer programmer leads a ...
- NIH Using Artificial Intelligence to Evaluate Stem Cell Qualityon November 14, 2019 at 1:22 pm
November 15, 2019 - NIH researchers used artificial intelligence to evaluate stem cell-derived “patches” of retinal pigment epithelium (RPE) tissue for implanting into the eyes of patients with ...
- Cocker spaniel with cancer to receive stem cells from mother living 4,000 miles awayon November 14, 2019 at 12:05 pm
A 6-year-old cocker spaniel in California that was recently diagnosed with cancer is slated to receive stem cells from her mother living 4,000 miles away in the United Kingdom. Coco the cocker spaniel ...
- What Percentage Of Human Stem Cells Institute PJSC (MCX:ISKJ) Shares Do Insiders Own?on November 14, 2019 at 3:12 am
If you want to know who really controls Human Stem Cells Institute PJSC (MCX:ISKJ), then you'll have to look at the makeup of its share registry. Large companies usually have institutions as ...
- Epithelial Stem Cells Market Growing and Future Trend by 2029 | 3Dmatrix, Aldagen, and Hybrid Organon November 13, 2019 at 9:34 pm
Nov 14, 2019 (WiredRelease via COMTEX) -- A Precise market analysis on Global Epithelial Stem Cells Product Market | Know Up Trends And More About Industry Tycoons, Emerging Growth Factors, ...
via Bing News